Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Raised to $60 at Piper Jaffray

October 26, 2017 4:36 AM
Piper Jaffray raised its price target on Sarepta Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles